Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01696669 Background | Mar 2010 → Dec 2017 | Ewing sarcoma | Spanish Group for Research in Sarcomas | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | “* G-CSF: 5 micrograms/kg/day SC.” NCT01696669 ↗ |
| Route | Subcutaneous | “5 micrograms/kg/day SC” NCT01696669 ↗ |